Announced
Synopsis
MML Growth Capital Partners, a mid-market private equity firm, agreed to invest in Cruinn Diagnostics, a laboratory equipment supplier, for €12m. "We are delighted to receive this investment from MML. This investment will give Cruinn the additional financial support to expand in its target markets," Jack Nolan, Cruinn Managing Director.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.